Independent register of U.S. FDA drug recalls · updated Oct 13, 2026
RxRecalls Get alerts

Class II drug recalls - moderate risk

Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.

14,543 recalls, newest first.

Class II · Moderate risk

Nature-Throid

CGMP Deviations

Terminated cGMP deviation Preferred Pharmaceuticals, Inc. NDC 68788-7605-09 D-1624-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations

Terminated cGMP deviation Preferred Pharmaceuticals, Inc. NDC 68788-7604-09 D-1623-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations

Terminated cGMP deviation Preferred Pharmaceuticals, Inc. NDC 68788-6860-09 D-1622-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations

Terminated cGMP deviation Preferred Pharmaceuticals, Inc. NDC 68788-9283-01 D-1621-2020
Class II · Moderate risk

Hand Sanitizer

CGMP Deviations: Product contains acetaldehyde and acetal above the allowable limits.

Terminated cGMP deviation Charles Paint Research Inc D-0792-2021
Class II · Moderate risk

Hand Sanitizer

CGMP Deviations: Product manufactured in same facility where product was found to contain acetaldehyde and acetal above the allowable limits.

Terminated cGMP deviation Charles Paint Research Inc D-0791-2021
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-5950-2 D-1613-2020
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-6150-2 D-1612-2020
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-5850-2 D-1611-2020
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-6050-2 D-1610-2020
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-5750-2 D-1609-2020
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-5650-2 D-1608-2020
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-5550-2 D-1607-2020
Class II · Moderate risk

WP Thyroid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-5450-4 D-1606-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3312-4 D-1605-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3310-4 D-1604-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3309-4 D-1603-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3308-4 D-1602-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3307-4 D-1601-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3305-4 D-1600-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3303-4 D-1599-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3299-4 D-1598-2020
Class II · Moderate risk

Nature-Throid

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3302-4 D-1597-2020

Recalls by year